Up 600% Then Down 50% In 2 Days: What Is Going On With MNPR Stock?

The logo of AstraZeneca is displayed at the 6th China International Import Expo in Shanghai, China, ... [+] on November 6, 2023. (Photo by Costfoto/NurPhoto via Getty Images) NurPhoto via Getty Images The stock price of Monopar Therapeutics (NASDAQ: MNPR), a clinical-stage biopharmaceutical company, skyrocketed from levels of $5.25 on Monday, October 21, to$32.66 on Thursday, October 24, before falling to around $17 now. The 6x rise in a matter of days can be attributed to a major licensing development for ...